<DOC>
	<DOCNO>NCT01571596</DOCNO>
	<brief_summary>The primary purpose study assess safety efficacy repeat subcutaneous ( SC ) injection KRN23 adult subject X-Linked Hypophosphatemia ( XLH ) .</brief_summary>
	<brief_title>An Extension Study KRN23 Adults With X-Linked Hypophosphatemia</brief_title>
	<detailed_description />
	<mesh_term>Familial Hypophosphatemic Rickets</mesh_term>
	<mesh_term>Hypophosphatemia</mesh_term>
	<criteria>1 . Satisfactory completion KKP 's sponsored KRN23INT001 clinical trial 2. eGFR â‰¥ 60 mL/min 3 . Corrected Ca &lt; 10.8 mg/dL 4 . For female childbearing potential , negative serum pregnancy test 5 . A willingness utilize adequate contraception become pregnant [ partner ( ) become pregnant ] study 6 . Additional inclusion criterion apply 1 . Subject experience safetyrelated event KRN23INT001 study 2 . Pregnant lactate female subject pregnant female planning become pregnant study 3 . Receipt live ( attenuate ) vaccine ( except influenza vaccine ) course KRN23INT001 study and/or study 4 . Condition could present concern either subject 's safety difficulty data interpretation 5 . Additional exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>XLH</keyword>
</DOC>